Yet another remarkable thing that aspirin appears to do: cut the risk of pancreatic cancer by 50 percent. A Yale University news release
reports that researchers at the school studied data from a Connecticut population of 362 newly diagnosed pancreatic cancer patients and a control group of 690 disease-free people. The study looked at regular use of both low-dose aspirin (75 to 325 mg. per day, taken for heart disease prevention) and regular-dose aspirin (325 to 1,200 mg. taken for pain or anti-inflammation purposes). What did they find? Both low-dose and regular-dose aspirin reduced the risk for developing pancreatic cancer by half, but wait, there’s more: among people who took aspirin for more than 10 years, the risk reduction was 60 percent. Pancreatic cancer, the researchers point out, is among the deadliest cancers, with the five-year survival rate at less than 5 percent. By the time it is diagnosed, it is usually too late. Read more from Yale.
Health, fitness and lifestyle tips for people over 50 who still like to play hard
Sunday, April 20, 2025
“Yet another remarkable thing that cancer appears to do: cut the risk of pancreatic cancer by 50 percent.”
I think you need to have someone check your work before submission for publication.
You are right about that, thanks.
Good thing to know as I have been taking 85mg aspiring for over a decade.
My brother looks like a survivor after a 12-hour operation at the Mayo Clinic.(after chemotherapy)
And no spreading.
Pingback: Books | SportsGeezer